 Tara Hendry-Hofer
Concepts (198)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antidotes | 14 | 2023 | 135 | 4.250 |
Why?
| | Cyanides | 8 | 2023 | 46 | 1.930 |
Why?
| | Cobamides | 4 | 2022 | 19 | 1.590 |
Why?
| | Swine | 14 | 2023 | 687 | 1.420 |
Why?
| | Sulfides | 4 | 2022 | 93 | 1.390 |
Why?
| | Hydrogen Sulfide | 4 | 2022 | 40 | 1.180 |
Why?
| | Potassium Cyanide | 4 | 2021 | 18 | 1.120 |
Why?
| | Mustard Gas | 11 | 2018 | 117 | 1.100 |
Why?
| | Injections, Intramuscular | 6 | 2023 | 117 | 0.900 |
Why?
| | Chemical Warfare Agents | 10 | 2018 | 119 | 0.850 |
Why?
| | Tranexamic Acid | 1 | 2023 | 34 | 0.850 |
Why?
| | Antifibrinolytic Agents | 1 | 2023 | 43 | 0.840 |
Why?
| | Tetrathionic Acid | 2 | 2021 | 4 | 0.840 |
Why?
| | Fibrinolysis | 2 | 2023 | 126 | 0.830 |
Why?
| | Disease Models, Animal | 10 | 2023 | 3498 | 0.810 |
Why?
| | Poisoning | 2 | 2023 | 110 | 0.780 |
Why?
| | Sulfhydryl Compounds | 3 | 2022 | 176 | 0.710 |
Why?
| | Thiadiazoles | 1 | 2020 | 21 | 0.680 |
Why?
| | Hemorrhage | 1 | 2023 | 600 | 0.660 |
Why?
| | Inhalation Exposure | 9 | 2020 | 96 | 0.550 |
Why?
| | Airway Obstruction | 5 | 2014 | 160 | 0.440 |
Why?
| | Animals | 29 | 2023 | 31565 | 0.440 |
Why?
| | Thiosulfates | 3 | 2021 | 19 | 0.390 |
Why?
| | Fibrinolytic Agents | 3 | 2014 | 231 | 0.280 |
Why?
| | Respiratory Insufficiency | 3 | 2014 | 286 | 0.260 |
Why?
| | Glyoxylates | 2 | 2023 | 9 | 0.250 |
Why?
| | Administration, Oral | 4 | 2021 | 725 | 0.240 |
Why?
| | Rats, Sprague-Dawley | 12 | 2018 | 2182 | 0.240 |
Why?
| | Metalloporphyrins | 3 | 2016 | 103 | 0.230 |
Why?
| | Antioxidants | 4 | 2016 | 529 | 0.210 |
Why?
| | Random Allocation | 2 | 2020 | 328 | 0.210 |
Why?
| | Epithelial Cells | 3 | 2014 | 946 | 0.200 |
Why?
| | Lung | 5 | 2017 | 3521 | 0.200 |
Why?
| | Tissue Plasminogen Activator | 2 | 2014 | 204 | 0.200 |
Why?
| | Thromboplastin | 2 | 2012 | 69 | 0.190 |
Why?
| | Blood Coagulation Disorders | 1 | 2023 | 154 | 0.190 |
Why?
| | Memory | 1 | 2023 | 209 | 0.190 |
Why?
| | Bronchi | 3 | 2012 | 223 | 0.190 |
Why?
| | Respiratory Mucosa | 2 | 2014 | 251 | 0.180 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2023 | 156 | 0.180 |
Why?
| | Soil Pollutants | 1 | 2020 | 14 | 0.180 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2020 | 121 | 0.180 |
Why?
| | Disulfides | 1 | 2020 | 90 | 0.180 |
Why?
| | Chemically-Induced Disorders | 1 | 2019 | 2 | 0.160 |
Why?
| | Toxicokinetics | 1 | 2018 | 9 | 0.160 |
Why?
| | Toxicity Tests, Acute | 1 | 2018 | 9 | 0.160 |
Why?
| | Terrorism | 1 | 2018 | 23 | 0.160 |
Why?
| | Mass Casualty Incidents | 1 | 2018 | 37 | 0.150 |
Why?
| | Glycine | 1 | 2019 | 152 | 0.150 |
Why?
| | Zebrafish | 1 | 2022 | 413 | 0.150 |
Why?
| | Bronchiolitis Obliterans | 1 | 2018 | 66 | 0.150 |
Why?
| | Chlorine | 2 | 2015 | 62 | 0.150 |
Why?
| | Rats | 9 | 2021 | 4913 | 0.150 |
Why?
| | Arterioles | 1 | 2017 | 39 | 0.140 |
Why?
| | Bronchoalveolar Lavage Fluid | 7 | 2018 | 580 | 0.140 |
Why?
| | Risk | 1 | 2018 | 810 | 0.130 |
Why?
| | Administration, Inhalation | 5 | 2018 | 637 | 0.130 |
Why?
| | Factor VII | 2 | 2012 | 24 | 0.130 |
Why?
| | Environmental Exposure | 1 | 2019 | 372 | 0.130 |
Why?
| | Pulmonary Fibrosis | 1 | 2018 | 321 | 0.120 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2015 | 38 | 0.120 |
Why?
| | Oxidative Stress | 3 | 2016 | 1068 | 0.120 |
Why?
| | Thrombosis | 1 | 2017 | 295 | 0.120 |
Why?
| | Toxicity Tests | 1 | 2014 | 28 | 0.110 |
Why?
| | Lung Injury | 1 | 2016 | 192 | 0.110 |
Why?
| | Bronchitis | 1 | 2014 | 35 | 0.110 |
Why?
| | Thrombolytic Therapy | 1 | 2014 | 117 | 0.110 |
Why?
| | Myocytes, Cardiac | 2 | 2015 | 449 | 0.110 |
Why?
| | Male | 12 | 2020 | 55396 | 0.110 |
Why?
| | Reactive Oxygen Species | 2 | 2016 | 522 | 0.110 |
Why?
| | Receptor, PAR-2 | 1 | 2012 | 7 | 0.100 |
Why?
| | Heparin | 1 | 2014 | 225 | 0.100 |
Why?
| | Receptor, PAR-1 | 1 | 2012 | 21 | 0.100 |
Why?
| | Female | 6 | 2020 | 59324 | 0.100 |
Why?
| | Lipoproteins | 1 | 2013 | 159 | 0.100 |
Why?
| | Fibrin | 4 | 2013 | 63 | 0.100 |
Why?
| | Cell Culture Techniques | 1 | 2014 | 341 | 0.100 |
Why?
| | Heart Diseases | 1 | 2015 | 329 | 0.100 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 250 | 0.100 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 225 | 0.090 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2013 | 236 | 0.090 |
Why?
| | Reactive Nitrogen Species | 1 | 2011 | 21 | 0.090 |
Why?
| | Treatment Outcome | 3 | 2021 | 9049 | 0.090 |
Why?
| | Pneumonia | 1 | 2016 | 563 | 0.090 |
Why?
| | Nasal Cavity | 1 | 2011 | 46 | 0.090 |
Why?
| | Olfactory Mucosa | 1 | 2011 | 60 | 0.090 |
Why?
| | Humans | 12 | 2021 | 114045 | 0.090 |
Why?
| | Time Factors | 5 | 2019 | 6077 | 0.080 |
Why?
| | Pulmonary Artery | 1 | 2013 | 1024 | 0.070 |
Why?
| | Endothelium, Vascular | 1 | 2013 | 830 | 0.070 |
Why?
| | Kaplan-Meier Estimate | 2 | 2018 | 813 | 0.070 |
Why?
| | Models, Animal | 2 | 2021 | 340 | 0.070 |
Why?
| | Blotting, Western | 3 | 2013 | 1143 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2018 | 1836 | 0.050 |
Why?
| | Hydrogen Cyanide | 1 | 2022 | 5 | 0.050 |
Why?
| | Granuloma, Respiratory Tract | 1 | 2002 | 12 | 0.050 |
Why?
| | Microdissection | 2 | 2013 | 15 | 0.050 |
Why?
| | Pyruvic Acid | 1 | 2022 | 42 | 0.050 |
Why?
| | Gene Knockdown Techniques | 2 | 2013 | 301 | 0.050 |
Why?
| | Patch Tests | 1 | 2002 | 51 | 0.050 |
Why?
| | Trachea | 2 | 2014 | 223 | 0.050 |
Why?
| | Cricetulus | 1 | 2021 | 97 | 0.050 |
Why?
| | CHO Cells | 1 | 2021 | 137 | 0.050 |
Why?
| | Fumigation | 1 | 2020 | 2 | 0.050 |
Why?
| | Cricetinae | 1 | 2021 | 252 | 0.050 |
Why?
| | Beryllium | 1 | 2002 | 146 | 0.050 |
Why?
| | RNA, Small Interfering | 2 | 2013 | 534 | 0.040 |
Why?
| | Chromatography, Liquid | 1 | 2022 | 345 | 0.040 |
Why?
| | Immunoglobulin M | 2 | 2013 | 245 | 0.040 |
Why?
| | Pesticides | 1 | 2020 | 49 | 0.040 |
Why?
| | Mammals | 1 | 2022 | 241 | 0.040 |
Why?
| | Rabbits | 1 | 2021 | 733 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2022 | 410 | 0.040 |
Why?
| | Mice | 3 | 2023 | 14843 | 0.040 |
Why?
| | Oxygen | 2 | 2014 | 851 | 0.040 |
Why?
| | T-Lymphocyte Subsets | 1 | 2002 | 383 | 0.040 |
Why?
| | Poisons | 1 | 2019 | 21 | 0.040 |
Why?
| | Phosphorylation | 1 | 2023 | 1558 | 0.040 |
Why?
| | Hippocampus | 1 | 2023 | 690 | 0.040 |
Why?
| | Apnea | 1 | 2018 | 17 | 0.040 |
Why?
| | Administration, Intravenous | 1 | 2018 | 122 | 0.040 |
Why?
| | Hemodynamics | 1 | 2023 | 1015 | 0.040 |
Why?
| | Lymphocyte Activation | 1 | 2002 | 1036 | 0.040 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2018 | 80 | 0.040 |
Why?
| | Receptor, Platelet-Derived Growth Factor alpha | 1 | 2018 | 40 | 0.040 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2018 | 75 | 0.040 |
Why?
| | Peptides | 1 | 2023 | 847 | 0.040 |
Why?
| | Hypotension | 1 | 2018 | 115 | 0.040 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2018 | 153 | 0.040 |
Why?
| | Platelet Aggregation | 1 | 2017 | 90 | 0.040 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2017 | 79 | 0.030 |
Why?
| | Computed Tomography Angiography | 1 | 2017 | 100 | 0.030 |
Why?
| | Proteins | 2 | 2013 | 906 | 0.030 |
Why?
| | Monitoring, Physiologic | 1 | 2018 | 248 | 0.030 |
Why?
| | Respiratory Function Tests | 1 | 2018 | 522 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2015 | 3861 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2019 | 949 | 0.030 |
Why?
| | Survival Analysis | 1 | 2018 | 1206 | 0.030 |
Why?
| | Etiocholanolone | 1 | 2015 | 7 | 0.030 |
Why?
| | Ranolazine | 1 | 2015 | 22 | 0.030 |
Why?
| | Neurons | 1 | 2023 | 1277 | 0.030 |
Why?
| | Cell Proliferation | 2 | 2013 | 2173 | 0.030 |
Why?
| | Thiocyanates | 1 | 2015 | 29 | 0.030 |
Why?
| | Mitochondria, Heart | 1 | 2015 | 72 | 0.030 |
Why?
| | Cell Movement | 2 | 2013 | 863 | 0.030 |
Why?
| | Cardiotonic Agents | 1 | 2015 | 121 | 0.030 |
Why?
| | Apoptosis | 2 | 2015 | 2349 | 0.030 |
Why?
| | Drug Administration Routes | 1 | 2014 | 38 | 0.030 |
Why?
| | Pulmonary Ventilation | 1 | 2014 | 72 | 0.030 |
Why?
| | Blood Coagulation Tests | 1 | 2014 | 51 | 0.030 |
Why?
| | Respiration | 1 | 2014 | 180 | 0.030 |
Why?
| | Electric Impedance | 1 | 2014 | 100 | 0.030 |
Why?
| | Acidosis | 1 | 2014 | 86 | 0.030 |
Why?
| | Weight Loss | 1 | 2018 | 642 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2016 | 475 | 0.030 |
Why?
| | Prothrombin | 1 | 2013 | 22 | 0.030 |
Why?
| | Indicators and Reagents | 1 | 2013 | 99 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2015 | 213 | 0.030 |
Why?
| | Adenosine Triphosphate | 1 | 2015 | 428 | 0.030 |
Why?
| | Primary Cell Culture | 1 | 2013 | 148 | 0.030 |
Why?
| | Fibrinogen | 1 | 2013 | 143 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2014 | 714 | 0.030 |
Why?
| | Adenoviridae | 1 | 2013 | 184 | 0.030 |
Why?
| | Cell Hypoxia | 1 | 2013 | 221 | 0.030 |
Why?
| | Neovascularization, Physiologic | 1 | 2013 | 174 | 0.020 |
Why?
| | Factor Xa | 1 | 2011 | 32 | 0.020 |
Why?
| | Milk Proteins | 1 | 2011 | 36 | 0.020 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 133 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2013 | 337 | 0.020 |
Why?
| | Antigens, Surface | 1 | 2011 | 146 | 0.020 |
Why?
| | Lung Diseases | 1 | 2017 | 690 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2012 | 426 | 0.020 |
Why?
| | Blood Coagulation | 1 | 2012 | 200 | 0.020 |
Why?
| | Cell Death | 1 | 2012 | 322 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 787 | 0.020 |
Why?
| | Immunoenzyme Techniques | 1 | 2011 | 192 | 0.020 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2011 | 157 | 0.020 |
Why?
| | Wound Healing | 1 | 2012 | 254 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2013 | 1228 | 0.020 |
Why?
| | Myocardium | 1 | 2015 | 911 | 0.020 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2010 | 107 | 0.020 |
Why?
| | Capillary Permeability | 1 | 2010 | 137 | 0.020 |
Why?
| | Peroxidase | 1 | 2010 | 161 | 0.020 |
Why?
| | Erythrocytes | 1 | 2014 | 568 | 0.020 |
Why?
| | Cell Survival | 1 | 2012 | 1014 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2010 | 304 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2013 | 1624 | 0.020 |
Why?
| | Cytokines | 1 | 2016 | 1824 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2322 | 0.010 |
Why?
| | Genes, T-Cell Receptor beta | 1 | 2002 | 18 | 0.010 |
Why?
| | Biopsy, Needle | 1 | 2002 | 180 | 0.010 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2002 | 309 | 0.010 |
Why?
| | Signal Transduction | 1 | 2012 | 4501 | 0.010 |
Why?
| | Inflammation | 1 | 2010 | 2464 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2002 | 1981 | 0.010 |
Why?
| | Skin | 1 | 2002 | 653 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2002 | 2783 | 0.010 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2002 | 959 | 0.010 |
Why?
|
|
Hendry-Hofer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|